reflects the individual commitment and accountability of every employee in an atmosphere of improvement and innovation. embodies the mission to ensure our products, processes and services meet or exceed all applicable regulations, standards and customer expectations. incorporates our patient first mindset, reinforcing ho is most important in our ork. means all employees incorporate our quality imperative in everything e do, every day. Ongoing process improvements We facilitate ongoing quality progress through process improvements. For example, our practice of conducting limited market releases for key products demonstrates how we are adapting processes to further support the responsible development and expansion of new markets. Additionally, we engage in extensive post-market surveillance activities across our product portfolio to collect empirical and anecdotal evidence on the use of our devices. We also participate in routine auditing activities involving the U.S. Food and Drug Administration, EU notified bodies and country-specific regulators. In the event we detect an issue, we take immediate action in the best interest of patients and publicly post product advisories. Programming to reinforce our commitment Our Quality Catch recognition program for product builders at all manufacturing sites provides incentives for people to raise system or process concerns. Employees who identify ways to integrate quality improvements are recognized by supervisors and peers for contributions such as “Eagle Eye” and “Raise Your Hand” catches. In addition, our annual “Everyone Makes an Impact” events for employees around the world bring our quality policy to life by featuring people who share how they benefitted from our devices as patients. A one-company effort All of our quality processes and initiatives are supported by practices that prioritize a quality focus throughout the business, including: • Comprehensive pre-clinical science processes for in-vitro and in-vivo pre-clinical research, as well as evaluations of medical devices in the development phase; • Rigorous clinical trial standards and procedures for highly regulated clinical trials that generate publicly reported efficacy data; • Research and development supported by 10 global R&D Centers of Excellence that specialize in key areas of new product performance and identify best practices for product design; and • Close monitoring of ongoing product performance. For updates on our latest development efforts and our performance, see our most recent 2022 Performance Report. To learn more about the results of our work at Boston Scientific, visit our website. April 2023 © 2023 Boston Scientific | 3